By Angela Moon
NEW YORK (Reuters) - Wall Street was set for a higher open on Monday, rebounding from a decline in the previous session, amid merger and acquisition activity in the pharmaceuticals sector.
* U.S. drugmaker Pfizer Inc
* Pfizer made a 58.8 billion pounds ($98.9 billion) bid to AstraZeneca in January and said it had contacted its British rival again on April 26 to further discuss a takeover, which would be one of the biggest ever in the pharmaceuticals industry.
* Forest Laboratories Inc
* Furiex Pharmaceuticals shares jumped nearly 31 percent in premarket trading while Forest Laboratories shares rose 2.3 percent.
* Bank of America Corp
* Bank of America shares were down 4 percent in premarket trading.
* Charter Communications Inc
* U.S. March pending home sales data is due at 10:00 a.m. ET (1400 GMT), followed by the Dallas Fed Manufacturing Survey at 10:30 a.m.
* S&P 500 e-mini futures rose 3.5 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures rose 40 points and Nasdaq 100 futures added 4.5 points.
* U.S. President Barack Obama announced new sanctions against some Russians on Monday to stop President Vladimir Putin from fomenting a rebellion in eastern Ukraine, but said he was holding broader measures against Russia's economy "in reserve.
* U.S. stocks dropped Friday, weighed by consumer discretionary stocks, as bellwether names Amazon.com and Ford Motor fell after releasing their quarterly earnings. Amazon.com shares were down 0.6 percent in premarket trading on Monday.
* Despite Friday's decline, the S&P 500 finished nearly flat for the week and within 2 percent of its all-time intraday high.
(Editing by Bernadette Baum)